Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity

Journal of Clinical Virology

Volumn 74, Issue , 2016, Pages 82-87

  Nijskens, Charlotte M ^a   Pas, Suzan D ^a   Cornelissen, Jan ^a   Caliskan, Kadir ^a   Hoek, Rogier A S ^a   Hesselink, Dennis A ^a   van der Eijk, Annemiek A ^a   de Man, Robert A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chronic disease; Hepatitis E; HEV; Pre existent liver disease; Ribavirin; Solid organ transplant

Indexed keywords

ADALIMUMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; HYDROXYUREA; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; RIBAVIRIN; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CAUSE OF DEATH; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMIZED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MORBIDITY; NEPHROTIC SYNDROME; NETHERLANDS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TERTIARY CARE CENTER; TIME TO TREATMENT; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL CLEARANCE; VIREMIA; CLASSIFICATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84951850174     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.11.038     Document Type: Article

References (10)

1. Pas S.D., de Man R.A., Mulders C., Balk A.H., van Hal P.T., Weimar W., Koopmans M.P., Osterhaus A.D., van der Eijk A.A. Hepatitis E virus infection among solid organ transplant recipients, The Netherlands. Emerg. Infect. Dis. 2012, 18:869-872.
2. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., Remnarace R., Usama W., Farrington L., Hamad N., Sieberhagen C., Ellis V., Mitchell J., Hussaini S.H., Banks M., Ijaz S., Bendall R.P. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur. J. Gastroenterol. Hepatol. 2008, 20:784-790.
3. Drobeniuc J., Greene-Montfort T., Le N.T., Mixson-Hayden T.R., Ganova-Raeva L., Dong C., Novak R.T., Sharapov U.M., Tohme R.A., Teshale E., Kamili S., Teo C.G. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg. Infect. Dis. 2013, 19:218-222.
4. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., Dumortier J., Cannesson A., Cassuto-Viguier E., Thervet E., Conti F., Lebray P., Dalton H.R., Santella R., Kanaan N., Essig M., Mousson C., Radenne S., Roque-Afonso A.M., Izopet J., Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
5. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., Cointault O., Esposito L., Abravanel F., Danjoux M., Durand D., Vinel J.P., Izopet J., Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008, 358:811-817.
6. Kamar N., Abravanel F., Selves J., Garrouste C., Esposito L., Lavayssiere L., Cointault O., Ribes D., Cardeau I., Nogier M.B., Mansuy J.M., Muscari F., Peron J.M., Izopet J., Rostaing L. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010, 89:353-360.
7. Riezebos-Brilman A., Verschuuren E.A., van Son W.J., van Imhoff G.W., Brugemann J., Blokzijl H., Niesters H.G. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J. Clin. Virol. 2013, 58:509-514.
8. Peron J.M., Bureau C., Poirson H., Mansuy J.M., Alric L., Selves J., Dupuis E., Izopet J., Vinel J.P. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J. Viral Hepat. 2007, 14:298-303.
9. Dalton H.R., Hazeldine S., Banks M., Ijaz S., Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007, 369:1260.
10. Kamar N., Rostaing L., Legrand-Abravanel F., Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients?. Am. J. Transplant. 2013, 13:1935-1936.